NO984073L - Ned-regulerende resistent C3 konvertase - Google Patents

Ned-regulerende resistent C3 konvertase

Info

Publication number
NO984073L
NO984073L NO984073A NO984073A NO984073L NO 984073 L NO984073 L NO 984073L NO 984073 A NO984073 A NO 984073A NO 984073 A NO984073 A NO 984073A NO 984073 L NO984073 L NO 984073L
Authority
NO
Norway
Prior art keywords
convertase
regulating
resistant
regulating resistant
Prior art date
Application number
NO984073A
Other languages
English (en)
Norwegian (no)
Other versions
NO984073D0 (no
Inventor
Timothy Charles Farries
Richard Alexander Harrison
Original Assignee
Imutran Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9604865.7A external-priority patent/GB9604865D0/en
Priority claimed from GBGB9611896.3A external-priority patent/GB9611896D0/en
Priority claimed from GBGB9614293.0A external-priority patent/GB9614293D0/en
Priority claimed from GBGB9624028.8A external-priority patent/GB9624028D0/en
Application filed by Imutran Ltd filed Critical Imutran Ltd
Publication of NO984073D0 publication Critical patent/NO984073D0/no
Publication of NO984073L publication Critical patent/NO984073L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO984073A 1996-03-07 1998-09-04 Ned-regulerende resistent C3 konvertase NO984073L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9604865.7A GB9604865D0 (en) 1996-03-07 1996-03-07 Modified proteins
GBGB9611896.3A GB9611896D0 (en) 1996-06-07 1996-06-07 Modified proteins
GBGB9614293.0A GB9614293D0 (en) 1996-07-08 1996-07-08 Modified proteins
GBGB9624028.8A GB9624028D0 (en) 1996-11-19 1996-11-19 Modified proteins
PCT/GB1997/000603 WO1997032981A1 (en) 1996-03-07 1997-03-04 Down-regulation resistant c3 convertase

Publications (2)

Publication Number Publication Date
NO984073D0 NO984073D0 (no) 1998-09-04
NO984073L true NO984073L (no) 1998-11-02

Family

ID=27451421

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984073A NO984073L (no) 1996-03-07 1998-09-04 Ned-regulerende resistent C3 konvertase

Country Status (18)

Country Link
US (2) US6268485B1 (hu)
EP (1) EP0885301A1 (hu)
JP (1) JP2000515001A (hu)
KR (1) KR19990087571A (hu)
CN (1) CN1227359C (hu)
AR (1) AR006150A1 (hu)
AU (1) AU726187B2 (hu)
BR (1) BR9708005A (hu)
CA (1) CA2247615A1 (hu)
CZ (1) CZ283598A3 (hu)
HU (1) HUP9900789A3 (hu)
IL (1) IL125862A0 (hu)
NO (1) NO984073L (hu)
NZ (1) NZ331595A (hu)
PL (1) PL328706A1 (hu)
SK (1) SK121798A3 (hu)
TR (1) TR199801769T2 (hu)
WO (1) WO1997032981A1 (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040023874A1 (en) * 2002-03-15 2004-02-05 Burgess Catherine E. Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US7314717B2 (en) * 2001-04-30 2008-01-01 Nanogen Inc. Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons
US6998243B2 (en) * 2001-04-30 2006-02-14 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons
US6756476B2 (en) * 2001-04-30 2004-06-29 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons
GB0204154D0 (en) * 2002-02-22 2002-04-10 Adprotech Ltd Cat immunisation vectors
CA2687395C (en) * 2007-05-03 2017-07-11 Medizinische Universitat Innsbruck Complement factor h-derived short consensus repeat-antibody constructs
KR20150029002A (ko) * 2007-06-07 2015-03-17 제넨테크, 인크. 보체-관련 장애의 예방 및 치료를 위한 Ｃ３ｂ 항체 및 방법
RU2549468C2 (ru) * 2013-08-09 2015-04-27 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт нормальной физиологии имени П.К. Анохина" Российской академии медицинских наук (ФГБУ "НИИНФ им. П.К. Анохина" РАМН") Способ определения стабилизации с3-конвертазы классического пути активации комплемента человека
US11903996B2 (en) * 2015-10-07 2024-02-20 David C. Fritzinger Modulators of complement function

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661347A (en) 1982-11-12 1987-04-28 Scripps Clinic Cytotoxic compositions
NZ333949A (en) 1994-09-08 2000-06-23 Imutran Ltd Modified human C3 proteins as therapeutic agents

Also Published As

Publication number Publication date
BR9708005A (pt) 2000-01-04
SK121798A3 (en) 1999-04-13
AU726187B2 (en) 2000-11-02
JP2000515001A (ja) 2000-11-14
HUP9900789A2 (hu) 1999-07-28
US6268485B1 (en) 2001-07-31
HUP9900789A3 (en) 2001-10-29
WO1997032981A1 (en) 1997-09-12
EP0885301A1 (en) 1998-12-23
CZ283598A3 (cs) 1999-02-17
CN1214733A (zh) 1999-04-21
US20020068059A1 (en) 2002-06-06
CN1227359C (zh) 2005-11-16
NO984073D0 (no) 1998-09-04
NZ331595A (en) 2000-02-28
CA2247615A1 (en) 1997-09-12
TR199801769T2 (xx) 1998-11-23
KR19990087571A (ko) 1999-12-27
US7002001B2 (en) 2006-02-21
AR006150A1 (es) 1999-08-11
PL328706A1 (en) 1999-02-15
AU2225797A (en) 1997-09-22
IL125862A0 (en) 1999-04-11

Similar Documents

Publication Publication Date Title
NO985680L (no) Peptidderivater
NO983849D0 (no) Peptidderivater
DE59806407D1 (de) Drucktaster
DE69707369D1 (de) Elektromagnetischer Schalter
NO984073L (no) Ned-regulerende resistent C3 konvertase
NO304660L (no) L÷fteanordning
DE69712459D1 (de) Fritiergerät
ID17978A (id) Pembuatan 6-aminokapronitril
DE69616267T2 (de) Zeitschalter
NO970147D0 (no) Alarm
BR9711681A (pt) Novos m-todos
ID17636A (id) Pembuatan 6-aminokapronitril
NO995427D0 (no) Humanprohormonkonvertase 4
DE59811930D1 (de) Drucktaster
DE29602529U1 (de) Fritiervorrichtung
DE29611004U1 (de) Elektromagnetischer Schalter
DE29607082U1 (de) Schaltuhr
DE29704931U1 (de) Schwimmschalter
KR960036347U (ko) 팔찌
KR970049739U (ko) 철근 받침대
KR970001996U (ko) 철근받침대
KR960035547U (ko) 스위치 구조
DE69619813T2 (de) Schwimmkörper
DE29608779U1 (de) Zylinderspule
KR970059916U (ko) 콘센트 구조

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application